Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.
Scott Gottlieb, MD, will take on the new position “effective immediately.” UnitedHealth Group did not say what, if any, steering committee the former FDA lead will sit on.
Dubbed “Clearity,” the new health plans will have four tiers to choose from, allowing patients to select the provider and services that are right for them. The insurance is similar to a concierge care model, but backed by a potentially larger network.
Krista Nelson made the official announcement on LinkedIn. She replaces Patrick Conway, MD, CEO of the broader Optum, who had held dual roles. Nelson has been with UnitedHealthcare since 2017.
Six companies have settled with the city for as total of over $402M. Two remaining defendants, McKesson and AmerisourceBergen, will test their luck in court.
The company was accused of billing the government for prescriptions patients never received. Walgreens said the oversight was a result of a software error.
The study from the American Medical Association is based on data from commercial and Medicare Part D plans. The analysis found market share for PBMs is heavily concentrated, leading to higher drug costs.
The 2016 payout totaled $770 million, with $71 million going to executives at Steward Health Care. That year, the hospital chain reported a net loss of $300 million.